Is Glenmark Pharmaceuticals Limited stock a buy or sell right now?

Glenmark Pharmaceuticals Limited currently trades in a Neutral range, with momentum and trend indicators showing no clear direction.

What is Glenmark Pharmaceuticals Limited’s RSI?

RSI is 61.78, showing balanced momentum within the normal range.

What does MACD indicate for GLENMARK.NS?

MACD at 18.80 signals bullish momentum with buyers in control.

What are Glenmark Pharmaceuticals Limited’s key support and resistance levels?

Support sits around $1916.94, while resistance is near $2089.20. A breakout above $2089.20 would open the door for further upside.

Glenmark Pharmaceuticals Limited

GLENMARK.NS•NSE

Healthcare

Drug Manufacturers - Specialty & Generic

₹2124.30

₹65.70(3.19%)

Indian Market opens in 12h 38m

Glenmark Pharmaceuticals Limited (GLENMARK.NS) Stock Technical Analysis & Trading Signals

Live technical indicators, trading signals, and momentum insights for Glenmark Pharmaceuticals Limited (NSE:GLENMARK.NS).

Disclaimer for Technical Analysis Page

The technical indicators and trading signals shown on this page are for informational purposes only and do not constitute financial advice. Stock market investments involve risk, and past performance is not a guarantee of future results. Always conduct your own research or consult a licensed financial advisor before making investment decisions.Read our Full Disclaimer

GLENMARK.NS Technical Analysis Summary

Glenmark Pharmaceuticals Limited stock currently trades in a neutral range, with no clear dominance from buyers or sellers.

Overall Sentiment:Neutral

Momentum:Bullish (RSI: 61.78)

Trend Strength:Weak (ADX: 12.05)

Volatility:Medium (ATR: 50.13)

Support/Resistance:$1916.94 – $2089.20 (Bollinger Bands)

This mix signals that Glenmark Pharmaceuticals Limited is trading in a balanced range with no clear breakout yet.

Momentum Indicators

RSI (14): 61.78

Bullish

Above midpoint suggests upward bias.

Stochastic %K: 90.63

Bearish

Overbought levels may trigger pullback.

Williams %R: -4.03

Bearish

Overbought levels may trigger correction.

Rate of Change (ROC): 5.88

Strongly Bullish

Strong upside momentum.

Takeaway:Glenmark Pharmaceuticals Limited shows strong bullish momentum, with buyers firmly in control.

Trend & Volatility

MACD: 18.80

Bullish

Bullish, trend momentum is strengthening.

ADX: 12.05

Weak

Weak trend, market trading sideways.

ATR (14): 50.13

Rising

Rising volatility, market activity increasing.

CCI (14): 151.92

Bearish Risk

Bearish risk, overbought levels suggest caution.

Takeaway:Glenmark Pharmaceuticals Limited shows a neutral trend, with weak conviction and limited volatility.

Support & Resistance indicators

Bollinger Bands

Upper Band

$2089.20

Middle Band (SMA 20)

$2003.07

Lower Band

$1916.94

Current Position

Above Upper Band

Takeaway:Glenmark Pharmaceuticals Limited trades near the upper band, signaling overbought conditions and risk of pullback.

Keltner Channels

Upper Channel

$2119.69

Middle Line (EMA 20)

$2019.44

Lower Channel

$1919.18

Squeeze Status

Squeeze On

Takeaway:Glenmark Pharmaceuticals Limited trades near the upper channel, signaling resistance and risk of pullback.

Volume & Money Flow Analysis

On-Balance Volume8.95M

Money Flow Index65.22Bullish, inflows support continued momentum.

Relative Vigor Index58.07Neutral to Bullish, buyers hold a slight edge.

Overall Takeaway:GLENMARK.NS shows bullish money flow, with volume and vigor supporting buyers.

Technical Trading Signals Summary

Based on the current technical analysis of Glenmark Pharmaceuticals Limited, here are the key trading signals and recommendations:

Bullish Signals

RSI above 50 → positive momentum from buyers.

MACD above 0 → bullish trend confirmation.

Price trading above middle Bollinger Band → mid-term support intact.

MFI below 80 → room for more buying without overbought risk.

Bearish Signals

Price near upper Bollinger Band → potential resistance and pullback risk.

Overall Recommendation:Technical indicators for Glenmark Pharmaceuticals Limited are mixed, suggesting a Hold or wait-and-see approach.